Stocktoria
Cadrenal Therapeutics, Inc. CVKD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2023-01-20
Cadrenal Therapeutics, Inc. statistics & valuation
Market cap$8.7M
P / B3.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Return on assets | -305.9% | -105.2% | -98.1% | -862.8% |
| Return on equity | -483.3% | -143.2% | -108.6% | 121.0% |
| Current ratio | 2.72 | 3.77 | 10.27 | 0.55 |
Source: SEC EDGAR filings · CIK 0001937993 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.